Targeting senescent cells enhances adipogenesis and metabolic function in old age

Ming Xu, Allyson K. Palmer, Husheng Ding, Megan Weivoda, Tamar Pirtskhalava, Thomas A. White, Anna Sepe, Kurt O. Johnson, Michael B. Stout, Nino Giorgadze, Michael Dennis Jensen, Nathan K LeBrasseur, Tamar Tchkonia, James L Kirkland

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

Senescent cells accumulate in fat with aging. We previously found genetic clearance of senescent cells from progeroid INK-ATTAC mice prevents lipodystrophy. Here we show that primary human senescent fat progenitors secrete activin A and directly inhibit adipogenesis in nonsenescent progenitors. Blocking activin A partially restored lipid accumulation and expression of key adipogenic markers in differentiating progenitors exposed to senescent cells. Mouse fat tissue activin A increased with aging. Clearing senescent cells from 18-month-old naturally-aged INKATTAC mice reduced circulating activin A, blunted fat loss, and enhanced adipogenic transcription factor expression within 3 weeks. JAK inhibitor suppressed senescent cell activin A production and blunted senescent cell-mediated inhibition of adipogenesis. Eight weeks-treatment with ruxolitinib, an FDA-approved JAK1/2 inhibitor, reduced circulating activin A, preserved fat mass, reduced lipotoxicity, and increased insulin sensitivity in 22-month-old mice. Our study indicates targeting senescent cells or their products may alleviate age-related dysfunction of progenitors, adipose tissue, and metabolism.

Original languageEnglish (US)
Article numbere12997
JournaleLife
Volume4
Issue numberDECEMBER2015
DOIs
StatePublished - Dec 19 2015

Fingerprint

Adipogenesis
Fats
Aging of materials
Tissue
Lipodystrophy
Metabolism
activin A
Transcription Factors
Insulin Resistance
Adipose Tissue
Insulin
Lipids

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Targeting senescent cells enhances adipogenesis and metabolic function in old age. / Xu, Ming; Palmer, Allyson K.; Ding, Husheng; Weivoda, Megan; Pirtskhalava, Tamar; White, Thomas A.; Sepe, Anna; Johnson, Kurt O.; Stout, Michael B.; Giorgadze, Nino; Jensen, Michael Dennis; LeBrasseur, Nathan K; Tchkonia, Tamar; Kirkland, James L.

In: eLife, Vol. 4, No. DECEMBER2015, e12997, 19.12.2015.

Research output: Contribution to journalArticle

Xu, M, Palmer, AK, Ding, H, Weivoda, M, Pirtskhalava, T, White, TA, Sepe, A, Johnson, KO, Stout, MB, Giorgadze, N, Jensen, MD, LeBrasseur, NK, Tchkonia, T & Kirkland, JL 2015, 'Targeting senescent cells enhances adipogenesis and metabolic function in old age', eLife, vol. 4, no. DECEMBER2015, e12997. https://doi.org/10.7554/eLife.12997
Xu M, Palmer AK, Ding H, Weivoda M, Pirtskhalava T, White TA et al. Targeting senescent cells enhances adipogenesis and metabolic function in old age. eLife. 2015 Dec 19;4(DECEMBER2015). e12997. https://doi.org/10.7554/eLife.12997
Xu, Ming ; Palmer, Allyson K. ; Ding, Husheng ; Weivoda, Megan ; Pirtskhalava, Tamar ; White, Thomas A. ; Sepe, Anna ; Johnson, Kurt O. ; Stout, Michael B. ; Giorgadze, Nino ; Jensen, Michael Dennis ; LeBrasseur, Nathan K ; Tchkonia, Tamar ; Kirkland, James L. / Targeting senescent cells enhances adipogenesis and metabolic function in old age. In: eLife. 2015 ; Vol. 4, No. DECEMBER2015.
@article{5a39cfea3ed04fb1a1946d26d871c0f3,
title = "Targeting senescent cells enhances adipogenesis and metabolic function in old age",
abstract = "Senescent cells accumulate in fat with aging. We previously found genetic clearance of senescent cells from progeroid INK-ATTAC mice prevents lipodystrophy. Here we show that primary human senescent fat progenitors secrete activin A and directly inhibit adipogenesis in nonsenescent progenitors. Blocking activin A partially restored lipid accumulation and expression of key adipogenic markers in differentiating progenitors exposed to senescent cells. Mouse fat tissue activin A increased with aging. Clearing senescent cells from 18-month-old naturally-aged INKATTAC mice reduced circulating activin A, blunted fat loss, and enhanced adipogenic transcription factor expression within 3 weeks. JAK inhibitor suppressed senescent cell activin A production and blunted senescent cell-mediated inhibition of adipogenesis. Eight weeks-treatment with ruxolitinib, an FDA-approved JAK1/2 inhibitor, reduced circulating activin A, preserved fat mass, reduced lipotoxicity, and increased insulin sensitivity in 22-month-old mice. Our study indicates targeting senescent cells or their products may alleviate age-related dysfunction of progenitors, adipose tissue, and metabolism.",
author = "Ming Xu and Palmer, {Allyson K.} and Husheng Ding and Megan Weivoda and Tamar Pirtskhalava and White, {Thomas A.} and Anna Sepe and Johnson, {Kurt O.} and Stout, {Michael B.} and Nino Giorgadze and Jensen, {Michael Dennis} and LeBrasseur, {Nathan K} and Tamar Tchkonia and Kirkland, {James L}",
year = "2015",
month = "12",
day = "19",
doi = "10.7554/eLife.12997",
language = "English (US)",
volume = "4",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications",
number = "DECEMBER2015",

}

TY - JOUR

T1 - Targeting senescent cells enhances adipogenesis and metabolic function in old age

AU - Xu, Ming

AU - Palmer, Allyson K.

AU - Ding, Husheng

AU - Weivoda, Megan

AU - Pirtskhalava, Tamar

AU - White, Thomas A.

AU - Sepe, Anna

AU - Johnson, Kurt O.

AU - Stout, Michael B.

AU - Giorgadze, Nino

AU - Jensen, Michael Dennis

AU - LeBrasseur, Nathan K

AU - Tchkonia, Tamar

AU - Kirkland, James L

PY - 2015/12/19

Y1 - 2015/12/19

N2 - Senescent cells accumulate in fat with aging. We previously found genetic clearance of senescent cells from progeroid INK-ATTAC mice prevents lipodystrophy. Here we show that primary human senescent fat progenitors secrete activin A and directly inhibit adipogenesis in nonsenescent progenitors. Blocking activin A partially restored lipid accumulation and expression of key adipogenic markers in differentiating progenitors exposed to senescent cells. Mouse fat tissue activin A increased with aging. Clearing senescent cells from 18-month-old naturally-aged INKATTAC mice reduced circulating activin A, blunted fat loss, and enhanced adipogenic transcription factor expression within 3 weeks. JAK inhibitor suppressed senescent cell activin A production and blunted senescent cell-mediated inhibition of adipogenesis. Eight weeks-treatment with ruxolitinib, an FDA-approved JAK1/2 inhibitor, reduced circulating activin A, preserved fat mass, reduced lipotoxicity, and increased insulin sensitivity in 22-month-old mice. Our study indicates targeting senescent cells or their products may alleviate age-related dysfunction of progenitors, adipose tissue, and metabolism.

AB - Senescent cells accumulate in fat with aging. We previously found genetic clearance of senescent cells from progeroid INK-ATTAC mice prevents lipodystrophy. Here we show that primary human senescent fat progenitors secrete activin A and directly inhibit adipogenesis in nonsenescent progenitors. Blocking activin A partially restored lipid accumulation and expression of key adipogenic markers in differentiating progenitors exposed to senescent cells. Mouse fat tissue activin A increased with aging. Clearing senescent cells from 18-month-old naturally-aged INKATTAC mice reduced circulating activin A, blunted fat loss, and enhanced adipogenic transcription factor expression within 3 weeks. JAK inhibitor suppressed senescent cell activin A production and blunted senescent cell-mediated inhibition of adipogenesis. Eight weeks-treatment with ruxolitinib, an FDA-approved JAK1/2 inhibitor, reduced circulating activin A, preserved fat mass, reduced lipotoxicity, and increased insulin sensitivity in 22-month-old mice. Our study indicates targeting senescent cells or their products may alleviate age-related dysfunction of progenitors, adipose tissue, and metabolism.

UR - http://www.scopus.com/inward/record.url?scp=84988603034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988603034&partnerID=8YFLogxK

U2 - 10.7554/eLife.12997

DO - 10.7554/eLife.12997

M3 - Article

C2 - 26687007

AN - SCOPUS:84988603034

VL - 4

JO - eLife

JF - eLife

SN - 2050-084X

IS - DECEMBER2015

M1 - e12997

ER -